Cargando…
sLe(x) expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator
OBJECTIVE: Mucin 1 (MUC1/EMA) and sialyl Lewis X (sLe(x)) indicate polarity reversal in invasive micropapillary carcinoma (IMPC). The purpose of this study was to evaluate the expression of MUC1/EMA and sLe(x) and to assess their diagnostic and prognostic value in patients with IMPC. METHODS: The ex...
Autores principales: | Song, Yawen, Sun, Hui, Wu, Kailiang, Lyu, Jianke, Zhang, Jingyue, Gu, Feng, Ma, Yongjie, Shen, Beibei, Wang, Chijuan, Chen, Xiaojiao, Xu, Jing, Li, Weidong, Liu, Fangfang, Fu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185870/ https://www.ncbi.nlm.nih.gov/pubmed/33893728 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0422 |
Ejemplares similares
-
Spatial transcriptomics reveals gene expression characteristics in invasive micropapillary carcinoma of the breast
por: Lv, Jianke, et al.
Publicado: (2021) -
PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast
por: Zhi, Renyong, et al.
Publicado: (2023) -
Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast
por: Shi, Qianqian, et al.
Publicado: (2022) -
Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma
por: Liu, Bingbing, et al.
Publicado: (2017) -
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)